Status:
WITHDRAWN
A Pilot Study Testing the Effects of Chemical Peels in Patients With Rosacea
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Rosacea
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study is a prospective, randomized, one-site therapeutic trial of 15% trichloroacetic acid (TCA) and 30% salicylic acid peels for rosacea. Two peels will be applied topically 4 weeks apart, and th...
Detailed Description
Patients with a diagnosis of rosacea will be included. Peels will be performed at no cost to participants; funding will be supplied by the UT Southwestern Dermatology department. A total of 20 patient...
Eligibility Criteria
Inclusion
- diagnosis of rosacea, with both papular/pustular lesions and facial erythema
Exclusion
- patients with active skin infection involving the face
- patients with severe nodular or phymatous rosacea with ocular involvement
- patients with other dermatoses that may interfere with the evaluation of rosacea
- patients who are pregnant or breastfeeding
- use of isotretinoin within the last year
- history of hypersensitivity to chemical peeling
- patients who easily scar or have dyspigmentation tendencies
- patients who continue to experience excessive sun exposure
- patients planning to change or initiate other treatments for their rosacea during the study period
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04889703
Start Date
December 1 2022
End Date
May 1 2024
Last Update
March 1 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.